Salta al contenuto principale
Passa alla visualizzazione normale.

VITO DI MARCO

Pubblicazioni

Data Titolo Tipologia Scheda
2024 Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria Articolo in rivista Vai
2024 Factors Associated with Primary Liver Cancer Survival in a Southern Italian Setting in a Changing Epidemiological Scenario Articolo in rivista Vai
2023 Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination Articolo in rivista Vai
2023 Adverse events in gastrointestinal endoscopy: Validation of the AGREE classification in a real-life 5-year setting Articolo in rivista Vai
2023 Development of a Thalassemia International Prognostic Scoring System (TIPSS) Articolo in rivista Vai
2023 Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease Articolo in rivista Vai
2023 Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study Articolo in rivista Vai
2023 Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease Articolo in rivista Vai
2022 Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence Articolo in rivista Vai
2022 A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2022 A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2022 Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development Articolo in rivista Vai
2022 Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals Articolo in rivista Vai
2022 Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis Articolo in rivista Vai
2022 Protective benefit of minimally invasive liver surgery for hepatocellular carcinoma prior to transplant Articolo in rivista Vai
2022 Hepatitis C: Standard of Treatment and What to Do for Global Elimination Articolo in rivista Vai
2022 HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis Articolo in rivista Vai
2022 RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices Articolo in rivista Vai
2022 AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD Articolo in rivista Vai
2022 Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders Articolo in rivista Vai
2021 Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes Articolo in rivista Vai
2021 Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease Articolo in rivista Vai
2021 Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia Recensione in rivista Vai
2021 Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience Articolo in rivista Vai
2021 Perception of the role of food and dietary modifications in patients with inflammatory bowel disease: Impact on lifestyle Articolo in rivista Vai
2021 Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia Articolo in rivista Vai
2021 First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials Articolo in rivista Vai
2021 Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C Articolo in rivista Vai
2021 Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach Articolo in rivista Vai
2021 NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease Articolo in rivista Vai
2021 Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy Articolo in rivista Vai
2021 Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population Articolo in rivista Vai
2021 Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort Articolo in rivista Vai
2021 Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study Articolo in rivista Vai
2021 Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C Articolo in rivista Vai
2021 Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals Articolo in rivista Vai
2020 Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease Articolo in rivista Vai
2020 A complication risk score to evaluate clinical severity of thalassaemia syndromes Articolo in rivista Vai
2020 Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study Articolo in rivista Vai
2020 Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition Articolo in rivista Vai
2020 Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis Articolo in rivista Vai
2020 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Vai
2020 Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study Articolo in rivista Vai
2020 Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the Management of Primary Liver Tumors Articolo in rivista Vai
2020 Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage Articolo in rivista Vai
2020 Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) Articolo in rivista Vai
2020 On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites Articolo in rivista Vai
2020 Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study Articolo in rivista Vai
2020 PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease Articolo in rivista Vai
2019 Liver stiffness quantification in patients with non-alcoholic steatohepatitis: comparison of shear wave elastography and transient elastography with liver biopsy correlation Abstract in atti di convegno pubblicato in rivista Vai
2019 Current epidemiology of HCV in Sicily: the RESIST-HCV model Abstract in atti di convegno pubblicato in rivista Vai
2019 Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Abstract in atti di convegno pubblicato in rivista Vai
2019 Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients Articolo in rivista Vai
2019 NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients Articolo in rivista Vai
2019 Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) Articolo in rivista Vai
2019 Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy Articolo in rivista Vai
2019 Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience Articolo in rivista Vai
2019 Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group. Articolo in rivista Vai
2019 AISF position paper on HCV in immunocompromised patients Articolo in rivista Vai
2019 Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients Articolo in rivista Vai
2019 Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience Articolo in rivista Vai
2019 Update of the statements on biology and clinical impact of occult hepatitis B virus infection Articolo in rivista Vai
2019 IMPACT OF NON-ALCOHOLIC FATTY LIVER DISEASE ON CARDIOVASCULAR RISK IN A GENERAL POPULATION Abstract in atti di convegno pubblicato in rivista Vai
2019 Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. Articolo in rivista Vai
2018 HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals Articolo in rivista Vai
2018 Management of HCV-Related Liver Disease in Hemophilia and Thalassemia Articolo in rivista Vai
2018 Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Articolo in rivista Vai
2018 Breaking bad news: How to cope Lettera Vai
2018 Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents Articolo in rivista Vai
2018 Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population Articolo in rivista Vai
2018 Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Articolo in rivista Vai
2018 Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus. Articolo in rivista Vai
2018 Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals. Articolo in rivista Vai
2018 Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort Poster pubblicato in rivista Vai
2018 High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma. Articolo in rivista Vai
2018 The course of oesophagogastric varices in patients with cirrhosis after DAA-induced HCV clearance Abstract in atti di convegno pubblicato in rivista Vai
2018 Real life experiences in HCV management in 2018 Articolo in rivista Vai
2018 Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis Articolo in rivista Vai
2018 Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus Articolo in rivista Vai
2018 Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis Articolo in rivista Vai
2017 Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response Articolo in rivista Vai
2017 Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel Articolo in rivista Vai
2017 Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2017 Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD Articolo in rivista Vai
2017 Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study Articolo in rivista Vai
2017 Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication Articolo in rivista Vai
2017 Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2017 Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity Articolo in rivista Vai
2017 Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies Articolo in rivista Vai
2017 Current and future challenges in HCV: insights from an Italian experts panel Articolo in rivista Vai
2017 Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies Articolo in rivista Vai
2017 Emerging Increase in the prevalence and severity of nonalcoholic fatty liver disease: epidemiological study from general Mediterranean population Abstract in atti di convegno pubblicato in rivista Vai
2017 Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values Articolo in rivista Vai
2016 The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease Articolo in rivista Vai
2016 Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension Articolo in rivista Vai
2016 Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model Articolo in rivista Vai
2016 Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. Articolo in rivista Vai
2016 HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels Articolo in rivista Vai
2016 The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases Articolo in rivista Vai
2016 Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication? Articolo in rivista Vai
2016 TM6SF2 rs58542926 is not associated with steatosis and fibrosis in largecohort of patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2015 Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease Articolo in rivista Vai
2015 The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease Articolo in rivista Vai
2015 The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. Articolo in rivista Vai
2015 PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C Articolo in rivista Vai
2015 Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis Articolo in rivista Vai
2015 The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity Abstract in rivista Vai
2015 Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program Articolo in rivista Vai
2015 Impact of HBV genotypes A and D genetic variability on infection evolution Articolo in rivista Vai
2015 Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis Articolo in rivista Vai
2015 Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2015 HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome Articolo in rivista Vai
2015 Comparison of Histochemical Staining Methods and Correlation with Transient Elastography in Acute Hepatitis. Articolo in rivista Vai
2014 Targeted Therapies in Hepatocellular Carcinoma Articolo in rivista Vai
2014 Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin Articolo in rivista Vai
2014 Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors Articolo in rivista Vai
2014 An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2014 The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene Abstract in rivista Vai
2014 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM Proceedings Vai
2014 Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2013 Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B Articolo in rivista Vai
2013 Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Vai
2013 Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis Articolo in rivista Vai
2013 Association of vitamin D serum levels and its common genetic determinants with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Proceedings Vai
2013 PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease Articolo in rivista Vai
2013 Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Articolo in rivista Vai
2013 Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response Abstract in rivista Vai
2013 Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients Articolo in rivista Vai
2013 Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance Articolo in rivista Vai
2013 High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2013 Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. Articolo in rivista Vai
2013 HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC Abstract in rivista Vai
2013 A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis Abstract in rivista Vai
2013 Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis. Articolo in rivista Vai
2013 Sorafenib: from literature to clinical practice Articolo in rivista Vai
2012 Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study Articolo in rivista Vai
2012 Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. Articolo in rivista Vai
2012 Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. Articolo in rivista Vai
2012 IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Articolo in rivista Vai
2012 HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years Articolo in rivista Vai
2012 Cost-Effectiveness of Boceprevir or Telaprevir for Untreated Patients with Genotype 1 Chronic Hepatitis C Articolo in rivista Vai
2012 Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. Articolo in rivista Vai
2012 IL28B and PNPLA3 Polymorphisms Affect Histological Liver Damage in Patients with Non-alcoholic Fatty Liver Disease. Articolo in rivista Vai
2012 Current practice of chronic hepatitis B treatment in Southern Italy. Articolo in rivista Vai
2012 Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C Articolo in rivista Vai
2012 Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Articolo in rivista Vai
2012 Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease Articolo in rivista Vai
2012 Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV Abstract in rivista Vai
2012 Methylenetetrahydrofolate reductase homozygosis and low-density lipoproteins in patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2012 Hyperuricaemia: another metabolic feature affecting the severity of chronic hepatitis because of HCV infection. Articolo in rivista Vai
2011 The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases Articolo in rivista Vai
2011 TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Vai
2011 Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Articolo in rivista Vai
2011 Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation Articolo in rivista Vai
2011 Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation Articolo in rivista Vai
2011 Chronic hepatitis C in children is a mild and curable liver disease Recensione in rivista Vai
2011 Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Articolo in rivista Vai
2011 High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis Articolo in rivista Vai
2011 Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance Abstract in rivista Vai
2011 Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Articolo in rivista Vai
2011 Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis Recensione in rivista Vai
2011 Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations. Articolo in rivista Vai
2011 Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2011 Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Articolo in rivista Vai
2011 Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop Articolo in rivista Vai
2011 PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE Abstract in rivista Vai
2011 LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION Abstract in rivista Vai
2011 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Vai
2011 Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy Articolo in rivista Vai
2010 INSULIN RESISTANCE, STEATOSIS AND PROGRESSION OF FIBROSIS IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C Proceedings Vai
2010 HEPATIC STEATOSIS IS ASSOCIATED WITH SEVERE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B Proceedings Vai
2010 Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases. Articolo in rivista Vai
2010 Halitosis: could it be more than mere bad breath? Articolo in rivista Vai
2010 Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. Articolo in rivista Vai
2010 Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Articolo in rivista Vai
2010 LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C Abstract in rivista Vai
2010 PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? Abstract in rivista Vai
2010 Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Articolo in rivista Vai
2009 Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) - lack of interference by iron deposition. Articolo in rivista Vai
2009 PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response Proceedings Vai
2009 Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. Articolo in rivista Vai
2009 Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection Articolo in rivista Vai
2009 PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response Proceedings Vai
2009 Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy Articolo in rivista Vai
2009 Chronic hepatitis B: who to treat and which choice of treatment? Articolo in rivista Vai
2009 Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis Articolo in rivista Vai
2009 Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection Articolo in rivista Vai
2009 SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C Articolo in rivista Vai
2009 EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? Articolo in rivista Vai
2009 Histomorphology of healthy oral mucosa in untreated celiac patients: unexpected association with spongiosis. Articolo in rivista Vai
2009 Hyperferritinemia is a risk factor for steatosis in chronic liver disease. Articolo in rivista Vai
2009 PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE Abstract in rivista Vai
2009 HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION Abstract in rivista Vai
2009 Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Articolo in rivista Vai
2008 Serum BLYS/BAFF levels in acute hepatitis C predict clinical outcome Proceedings Vai
2008 Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. Articolo in rivista Vai
2008 Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay Articolo in rivista Vai
2008 Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Articolo in rivista Vai
2008 Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C. Articolo in rivista Vai
2008 751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS Articolo in rivista Vai
2008 Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis C virus genotype 1. Articolo in rivista Vai
2008 CLINICAL COURSE OF NIMESULIDE-INDUCED LIVER INJURY Proceedings Vai
2008 Metformina e pioglitazone in soggetti affetti da diabete mellito tipo 2 con steatosi epatica Proceedings Vai
2008 Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease Proceedings Vai
2008 Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease Proceedings Vai
2008 Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Articolo in rivista Vai
2008 Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems Articolo in rivista Vai
2008 Retinol-binding protein 4 (RBP4) : a new marker of G1 HCV-induced steatosis Articolo in rivista Vai
2008 Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C Articolo in rivista Vai
2007 Seeding after radiofrequency thermal ablation of hepatocellular carcinoma in cirrhosis: a prospective study Proceedings Vai
2007 Oral pathology in untreated coeliac disease Articolo in rivista Vai
2007 Oral Mucosa of celiac disease patients produces anti-endomysial and anti-transglutaminase antibodes. Diagnostic usefulness of an in vitro culture system Articolo in rivista Vai
2007 HCV clearance among hemophiliacs and beta-thalassemics Abstract in rivista Vai
2007 The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study Proceedings Vai
2007 INSULIN RESISTANCE AND SEVERITY OF FIBROSIS IN HCV GENOTYPE 1 CHRONIC HEPATITIS. Proceedings Vai
2007 STAGING OF FIBROSIS BY LIVER STIFFNESS MEASUREMENT IN THALASSEMICS WITH IRON OVERLOAD Proceedings Vai
2007 The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study Proceedings Vai
2007 Mortality in patients with hepatocellular carcinoma predicted by six scoring: none is the winner Proceedings Vai
2007 Adefovir for lamivudine resistant HBV: More than meets the eye. Articolo in rivista Vai
2007 Oral Mucosa of celiac patients produces anti-endomysial and anti-transglutaminase antibodies. Diagnostic usefulness of an in vitro culture system. Proceedings Vai
2007 Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial Articolo in rivista Vai
2007 Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier Proceedings Vai
2007 VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS Proceedings Vai
2007 Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale Proceedings Vai
2007 The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. Articolo in rivista Vai
2007 Prophylaxis and treatment of hepatitis B in immunocompromised patients. Articolo in rivista Vai
2007 INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE Proceedings Vai
2006 Halitosis and HCV-related liver disease:true association Proceedings Vai
2006 Suggestive caratteristiche istomorfologiche della mucosa orale sana in pazienti affetti da morbo celiaco vs pazienti non celiaci:studio caso-controllo. Proceedings Vai
2006 A muticenter Italian Study od rescue adefovir dipivoxil therapy in lamivudine resistant patients: a 2 years analysis of 650 pATIENTS. Articolo in rivista Vai
2006 Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C Articolo in rivista Vai
2006 Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis. Articolo in rivista Vai
2006 Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Articolo in rivista Vai
2006 Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial Articolo in rivista Vai
2006 High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C Articolo in rivista Vai
2006 The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. Articolo in rivista Vai
2006 Histomorphological features of health oral mucosa in celiac patients:unexspected association with spongiosis. Proceedings Vai
2006 Histomorphological features of healthy oral mucosa in coeliac patients: unexpected association with spongiosis”. Proceedings Vai
2006 Adefovir and Lamivudine combination therapy is superior to adefovir monotherapy for lamivudine-resistant patients with HBeAg-negative chronic hepatitis B Articolo in rivista Vai
2005 Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir Proceedings Vai
2005 HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy Articolo in rivista Vai
2005 Current epidemiological trends and outcome in a large cohort of acute hepatitis C patients. Articolo in rivista Vai
2005 A multicenter Italian Study of rescue adefovir dipivoxil tehrapy in lamivudine resistant patients: a 2-year anlysis of 604 patients. Articolo in rivista Vai
2005 Congenital hepatic fibrosis: a very uncommon cause of pancytopenia in children. Articolo in rivista Vai
2005 Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center Articolo in rivista Vai
2005 Infezione occulta da HBV in pazienti con malattie oncoematologiche Proceedings Vai
2005 Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) Proceedings Vai
2005 Caratterizzazione biochimica e molecolare di ceppi di Mannheimia isolati da ovini siciliani. Proceedings Vai
2005 Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b Articolo in rivista Vai
2005 Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) Proceedings Vai
2005 Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study Articolo in rivista Vai
2004 Patologie da sovraccarico di ferro:recenti acquisizioni Articolo in rivista Vai
2004 The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing Abstract in rivista Vai
2004 Emocromatosi Articolo in rivista Vai
2004 Percutaneous radiofrequency therma ablation of small hepatocellular carcinoma: a prospective study Proceedings Vai
2004 PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION 8 RFTA) OF SMALL HEPATOCELLUALR CARCINOMA: A PROSPECTIVE STUDY Articolo in rivista Vai
2004 Caratterizzazione molecolare di ceppi di Mannheimia isolati da ovini siciliani Altro Vai
2004 La termoablazione nel trattamento delle neoplasie epatiche primitive e secondarie Articolo in rivista Vai
2004 Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine Articolo in rivista Vai
2004 PATTERNS DI RECIDIVA EPATICA CON MDCT DOPO TERMOABLAZIONE A RADIOFRAQUENZA Proceedings Vai
2004 HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin Articolo in rivista Vai
2004 Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial Articolo in rivista Vai
2004 Paraduodenal hernia: an uncommon cause of recurrent abdominal pain Articolo in rivista Vai
2004 Combination therapy with amantadine and interferon in naive patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials Articolo in rivista Vai
2004 Caratterizzazione molecolare di ceppi di Mannheimia isolati da ovini siciliani Proceedings Vai
2003 A patient with acute hepatitis C and possible IFN toxicity [2] Articolo in rivista Vai
2003 Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV Articolo in rivista Vai
2003 ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin Articolo in rivista Vai
2003 Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C Articolo in rivista Vai
2002 Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction Articolo in rivista Vai